Basics Avanos Medical, Inc. IPO Date: October 20, 2014 Sector: Healthcare Industry: Biotech Market Cap: $537.8M Activated in VL: True Average Daily Range Avg Daily Range: $0.49 | 1.60% Avg Daily Range (30 D): $0.21 | 1.83% Avg Daily Range (90 D): $0.21 | 1.79% Institutional Daily Volume Avg Daily Volume: .26M Avg Daily Volume (30 D): .4M Avg Daily Volume (90 D): .43M Trade Size Avg Trade Size (Sh.): 62 Avg Trade Size (Sh.) (30 D): 53 Avg Trade Size (Sh.) (90 D): 57 Institutional Trades Total Inst.Trades: 2,655 Avg Inst. Trade: $1.57M Avg Inst. Trade (30 D): $1.46M Avg Inst. Trade (90 D): $1.46M Avg Inst. Trade Volume: .05M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.55M Avg Closing Trade (30 D): $1.53M Avg Closing Trade (90 D): $1.38M Avg Closing Volume: 55.52K     News Aug 5, 2025 @ 2:14 PM Avanos (AVNS) Q2 2025 Earnings Call Transcript Source: The Motley Fool Dec 30, 2024 @ 12:58 PM United States Syringes, Needles and Urinary Cathet... Source: Researchandmarkets.Com Oct 6, 2024 @ 11:30 PM Bio Pharma Buffer Market to Reach $2.4 Billion, Gl... Source: Allied Market Research Aug 29, 2024 @ 12:17 PM Pain Management Devices Market to Witness 21.5 % C... Source: Globe Newswire Aug 5, 2024 @ 11:52 AM Is Phibro (PAHC) Stock Worth Retaining in Your Por... Source: N/A Financials   TTM Q1 2025 Q4 2024 Basic EPS $-1.66 $.14 $-8.64 Diluted EPS $-1.66 $.14 $-8.64 Revenue $ 175M $ 167.5M $ 179.6M Gross Profit $ 92.1M $ 89.8M $ 98M Net Income / Loss $ -76.8M $ 6.6M $ -397.3M Operating Income / Loss $ -74.5M $ 10.3M $ -418.5M Cost of Revenue $ 82.9M $ 77.7M $ 81.6M Net Cash Flow $ -6.7M $ -10.7M $ 18.7M PE Ratio     Splits May 15, 2006:   1:100